Colgate-Palmolive Company (CL)
Last Price$93.62.3%
Market Cap$86.5B
CL overview
Crunching data... Almost there!
1W 1.1%
1M (7.4%)
6M (0.0%)
YTD 18.5%
1Y 26.7%
3Y 28.3%
5Y 58.5%
10Y 73.9%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
CL key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
CL Intrinsic value
CL Intrinsic value overview
CL Historical intrinsic value
CL Financials
CL Income statement
Crunching data... Almost there!
CL Balance sheet
Crunching data... Almost there!
CL Cash flow statement
Crunching data... Almost there!
CL Financial ratios
CL Growth
Crunching data... Almost there!
CL Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more CL fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Colgate-Palmolive Company (CL) stock?
As of today, intrinsic value of Colgate-Palmolive Company is $56.1.
Is Colgate-Palmolive Company (CL) stock undervalued or overvalued?
As of today, Colgate-Palmolive Company is overvalued by 40.0%, compared to the current market share price of $93.6.
What is Colgate-Palmolive Company (CL) stock rating?
As of today, Colgate-Palmolive Company has a stock rating of 6 (out of 10), which is considered Good.
is Colgate-Palmolive Company (CL) a good stock to buy?
As of today, Colgate-Palmolive Company has a Good stock rating, which is 40.0% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.